MedPath

Sodium Citrate and Citric Acid

Sodium Citrate and Citric Acid Oral Solution USP

Approved
Approval ID

b3d5225c-0ee4-481e-b9ec-bc5e1321096d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 19, 2024

Manufacturers
FDA

Cardinal Health 107, LLC

DUNS: 118546603

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM CITRATE and CITRIC ACID MONOHYDRATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55154-5777
Product Classification
G
Generic Name
SODIUM CITRATE and CITRIC ACID MONOHYDRATE
Product Specifications
Route of AdministrationORAL
Effective DateJune 21, 2019
FDA Product Classification

INGREDIENTS (7)

POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ANHYDROUS CITRIC ACIDActive
Quantity: 334 mg in 5 mL
Code: XF417D3PSL
Classification: ACTIB
SODIUM CITRATE, UNSPECIFIED FORMActive
Quantity: 500 mg in 5 mL
Code: 1Q73Q2JULR
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 3/19/2024

Package/Label Display Panel

Sodium Citrate and Citric Acid Oral Solution USP

3 g/2 g per 30 mL

Sugar Free

5 Cups

Bag Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 6/21/2019

INDICATIONS AND USAGE

Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively.

Sodium Citrate and Citric Acid Oral Solution USP is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 6/21/2019

CONTRAINDICATIONS

Patients on sodium-restricted diets or with severe renal impairment.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 6/21/2019

ADVERSE REACTIONS

Sodium Citrate and Citric Acid Oral Solution USP is generally well tolerated, without any unpleasant side effects, when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of alkalosis, especially in the presence of hypocalcemia.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 6/21/2019

HOW SUPPLIED

Sodium Citrate and Citric Acid Oral Solution USP (colorless, grape flavor) is supplied in the following oral dosage forms:

Overbagged with 5x 30 mL unit dose cups per bag, 55154-5777-5

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 3/19/2024

Rx ONLY

Manufactured By:
Pharmaceutical Associates, Inc.
Greenville, SC 29605
www.paipharma.com

Distributed by:
Cardinal Health

Dublin, OH 43017

L53713070324

R06/16

DESCRIPTION SECTION

LOINC: 34089-3Updated: 3/19/2024

DESCRIPTION

Sodium Citrate and Citric Acid Oral Solution USP is a stable and pleasant- tasting systemic alkalizer containing sodium citrate and citric acid in a sugar-free base. It is a nonparticulate neutralizing buffer.

Sodium Citrate and Citric Acid Oral Solution USP contains in each teaspoonful (5 mL):

SODIUM CITRATE Dihydrate 500 mg (0.34 Molar)
CITRIC ACID Monohydrate 334 mg (0.32 Molar)

Each mL contains 1 mEq sodium ion and is equivalent to 1 mEq bicarbonate (HCO3).

INACTIVE INGREDIENTS: Flavoring, polyethylene glycol, propylene glycol, purified water, sodium benzoate, and sorbitol solution.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 6/21/2019

CLINICAL PHARMACOLOGY

Sodium citrate is absorbed and metabolized to sodium bicarbonate, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of sodium citrate is excreted in the urine unchanged.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 6/21/2019

PRECAUTIONS

Sodium Citrate and Citric Acid Oral Solution USP should be used with caution by patients with low urinary output unless under the supervision of a physician. This product should not be administered concurrently with aluminum- based antacids. Patients should be directed to dilute adequately with water and preferably, to take each dose after meals to avoid saline laxative effect. Sodium salts should be used cautiously in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy. Periodic examinations and determinations of serum electrolytes, particularly serum bicarbonate level, should be carried out in those patients with renal disease in order to avoid these complications.

OVERDOSAGE SECTION

LOINC: 34088-5Updated: 6/21/2019

OVERDOSAGE

Overdosage with sodium salts may cause diarrhea, nausea and vomiting, hypernoia, and convulsions.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 6/21/2019

DOSAGE AND ADMINISTRATION

Sodium Citrate and Citric Acid Oral Solution USP should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 6/21/2019

STORAGE:

Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from freezing.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Citrate and Citric Acid - FDA Drug Approval Details